Tartrate-resistant acid phosphatase
Tartrate-resistant acid phosphatase
Tartrate-resistant acid phosphatase (TRAP) is an enzyme that is expressed in various tissues and is involved in several physiological and pathological processes. It is a member of the acid phosphatase family and is characterized by its resistance to inhibition by tartrate, a property that distinguishes it from other acid phosphatases.
Structure and Function[edit | edit source]
TRAP is a glycoprotein enzyme that contains a binuclear iron center, which is essential for its catalytic activity. The enzyme is expressed in several isoforms, with TRAP 5a and TRAP 5b being the most studied. TRAP 5b is particularly important in bone metabolism, as it is secreted by osteoclasts, the cells responsible for bone resorption.
TRAP plays a role in the degradation of bone matrix by osteoclasts, contributing to the release of minerals and the breakdown of organic components. It is also involved in the regulation of macrophage function and has been implicated in the immune response.
Clinical Significance[edit | edit source]
Elevated levels of TRAP, particularly TRAP 5b, are associated with increased osteoclastic activity and bone resorption. This makes TRAP a useful biomarker in the diagnosis and monitoring of bone-related diseases such as osteoporosis, Paget's disease of bone, and certain types of bone cancer.
In addition to its role in bone metabolism, TRAP has been studied in the context of autoimmune diseases and inflammatory diseases, where it may contribute to the pathogenesis of these conditions.
Diagnostic Use[edit | edit source]
TRAP activity can be measured in serum or plasma samples, and its levels are often assessed in conjunction with other markers of bone turnover. The measurement of TRAP 5b is particularly useful in evaluating the effectiveness of treatments for bone diseases, as it reflects changes in osteoclast activity.
Research and Future Directions[edit | edit source]
Ongoing research is exploring the potential of TRAP as a therapeutic target in diseases characterized by excessive bone resorption. Inhibitors of TRAP activity are being investigated for their ability to reduce bone loss and improve bone density in conditions such as osteoporosis.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD